Home › Funds › Affinity Asset Advisors, LLC › NRIX

Affinity Asset Advisors, LLC position in NRIX

NURIX THERAPEUTICS INC · Health Care

Affinity Asset Advisors, LLC reported holding 967,620 shares of NRIX (NURIX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$22.9M, representing 1.07% of its reported portfolio and ranking #28 among its reported holdings. Affinity Asset Advisors, LLC has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)967.62K sh
Reported value held$22.94M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's NRIX position evolved

Affinity Asset Advisors, LLC first disclosed a stake in NRIX in Q3 2023 at 250,000 shares (US$2.0M). The position peaked in Q2 2026 at 967,620 shares, worth US$23.5M. Across 13 filings, Affinity Asset Advisors, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 967,620 shares valued at US$22.9M. Notable position changes include a 176% increase in Q4 2023 (shares rose 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 250.00K $1.97M New
Q4 2023 690.11K $7.12M Add
Q1 2024 810.25K $11.91M Add
Q2 2024 912.00K $19.03M Add
Q3 2024 860.40K $19.33M Reduce
Q4 2024 940.08K $17.71M Add
Q1 2025 810.67K $9.63M Reduce
Q2 2025 967.62K $11.02M Add
Q3 2025 967.62K $8.94M Hold
Q4 2025 967.62K $18.36M Hold
Q1 2026 967.62K $15.00M Hold
Q2 2026 967.62K $23.47M Hold
Q3 2026 967.62K $22.94M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held NRIX?

Affinity Asset Advisors, LLC has disclosed NRIX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Affinity Asset Advisors, LLC's current position in NRIX?

As of Q3 2026, Affinity Asset Advisors, LLC holds 967.62K shares of NRIX (NURIX THERAPEUTICS INC), valued at $22.94M, representing 1.07% of its reported portfolio and ranking #28.

Has Affinity Asset Advisors, LLC been buying or selling NRIX?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in NRIX. The position peaked in Q2 2026 at 967.62K shares.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.